Gastric Neuroendocrine Tumors from Long‐Term Proton Pump Inhibitor Users are Indolent Tumors with Good Prognosis

Aims Proton pump inhibitors (PPIs) are among the most widely used medications in the United States. Most PPI users have persistent hypergastrinemia during treatment. However, gastric neuroendocrine …

Read the full article here

Related Articles

DEN Open

Author Guidelines – DEN Open AIMS AND SCOPE EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS MANUSCRIPT CATEGORIES AND REQUIREMENTS SUBMISSION SUBMISSION PREPARING THE SUBMISSION AUTHOR LICENSING AND…